Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 47, Issue 12, Pages 2981-2983Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm049833g
Keywords
-
Categories
Ask authors/readers for more resources
In this communication we describe the design, synthesis, and evaluation of novel sultam hydroxamates 4 as MMP-2, -9, and -13 inhibitors. Compound 26 was found to be an active inhibitor (NIMP-2 IC50 = 1 nM) with 1000-fold selectivity over MMP-1 and good oral bioavailability (F = 43%) in mouse. An X-ray crystal structure of 26 in MMP-13 confirms the key hydrogen bonds and prime side binding in the active site.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available